Literature DB >> 7153975

Tranquillizer use in middle-aged British men.

R O Cummins, D G Cook, R C Hume, A G Shaper.   

Abstract

We have examined the use of tranquillizers by 7,735 middle-aged men currently enrolled in the British Regional Heart Study, a prospective study of cardiovascular disease in 24 towns throughout Great Britain. Tranquillizer use was reported by 620 men (8 per cent). There was a slightly greater prevalence of tranquillizer use in the older men and the non-manual workers. Men with physical disease diagnosed by their doctor or by objective measurements during the study were more likely to be using tranquillizers than men with no physical disease. This was most evident for ischaemic heart disease, however diagnosed, and for hypertension diagnosed by their doctors. There was an inverse relationship between drinking and tranquillizer usage: heavy drinkers had lower rates of usage. There was no association between tranquillizer use and smoking habits.This study indicates that tranquillizer use in these middle-aged men is little influenced by age, social class or smoking, but that there is a strong, positive association between tranquillizer use and the presence of doctor-diagnosed physical disease. While our data provide support for the suggestion that alcohol and tranquillizers may be used interchangeably by some individuals, this finding could also be an outcome of doctors' and patients' awareness of the undesirable effects of combining alcohol and tranquillizers.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7153975      PMCID: PMC1972844     

Source DB:  PubMed          Journal:  J R Coll Gen Pract        ISSN: 0035-8797


  21 in total

1.  The diagnosis of ischaemic heart pain and intermittent claudication in field surveys.

Authors:  G A ROSE
Journal:  Bull World Health Organ       Date:  1962       Impact factor: 9.408

2.  Relationship between physical and psychiatric disorder.

Authors:  M R Eastwood; M H Trevelyan
Journal:  Psychol Med       Date:  1972-11       Impact factor: 7.723

3.  Motivation for drinking among men: survey of a London suburb.

Authors:  G Edwards; C Hensman; J Chandler; J Peto
Journal:  Psychol Med       Date:  1972-08       Impact factor: 7.723

4.  Physical illness in psychiatric patients.

Authors:  G P Maguire; K L Granville-Grossman
Journal:  Br J Psychiatry       Date:  1968-11       Impact factor: 9.319

5.  Stress and coronary heart disease.

Authors:  M R Eastwood; H Trevelyan
Journal:  J Psychosom Res       Date:  1971-09       Impact factor: 3.006

6.  Smoking and drinking by middle-aged British men: effects of social class and town of residence.

Authors:  R O Cummins; A G Shaper; M Walker; C J Wale
Journal:  Br Med J (Clin Res Ed)       Date:  1981-12-05

7.  Relationships of stress, tranquilizers, and serum cholesterol levels in a sample population under study for coronary heart disease.

Authors:  J M Chapman; L G Reeder; F J Massey; E R Borun; B Picken; G G Browning; A H Coulson; D H Zimmerman
Journal:  Am J Epidemiol       Date:  1966-05       Impact factor: 4.897

8.  Coronary heart disease in the Western collaborative group study. A follow-up experience of two years.

Authors:  R H Rosenman; M Friedman; R Straus; M Wurm; C D Jenkins; H B Messinger
Journal:  JAMA       Date:  1966-01-10       Impact factor: 56.272

9.  British Regional Heart Study: geographic variations in cardiovascular mortality, and the role of water quality.

Authors:  S J Pocock; A G Shaper; D G Cook; R F Packham; R F Lacey; P Powell; P F Russell
Journal:  Br Med J       Date:  1980-05-24

10.  British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns.

Authors:  A G Shaper; S J Pocock; M Walker; N M Cohen; C J Wale; A G Thomson
Journal:  Br Med J (Clin Res Ed)       Date:  1981-07-18
View more
  1 in total

1.  Factors affecting the reporting of symptoms by hypertensive patients.

Authors:  M J Vandenburg; S J Evans; B J Kelly; F Bradshaw; W J Currie; W D Cooper
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.